
A novel treatment uniquely and selectively binds critical metals to interrupt enzyme function, returning cellular metals like Iron, copper, and zinc to homeostasis and turning off the underlying cause of cancer development and growth.
By targeting specific classes of enzymes through its metal binding properties, Telomir 1 is believed to selectively affect the key processes that drive the concentration and accumulation of iron and copper in the serum that affects diseases like hemochromatosis and cancer.
Up to 90% verified emails and mobile numbers, refreshed weekly.
Telomir Pharmaceuticals, Inc. operates in the Biotechnology Research industry and is headquartered in United States.
Telomir Pharmaceuticals, Inc. has approximately 2-10 employees employees.
Telomir Pharmaceuticals, Inc. is based in Tampa, Florida, United States.
Yes. Telomir Pharmaceuticals, Inc. is a publicly traded company.
You can reach Telomir Pharmaceuticals, Inc.’s investor relations department through the contact section on their official website or directly via the investor relations email listed in their latest SEC filings.
Up to 90% verified emails and mobile numbers, backed by weekly job-change alerts.
An email pattern tells you the format. It does not tell you who works there now or whether an address still delivers. Scalelist returns verified contacts, checked at the point you build the list.
Our team will be in touch soon. If you have any questions, please email us at info@scalelist.com
Just a few more details..
Our team will be in touch soon. If you have any questions, please email us at arnaud@scalelist.com